AVAILABILITY OF INFORMATION ABOUT OLD PERSONS IN EUROPEAN PUBLIC ASSESSMENT REPORTS AND SUMMARIES OF PRODUCT CHARACTERISTICS

被引：0
|
作者：
Beers, E. [1 ]
Jansen, P. A. F. [1 ,2 ]
Egberts, A. C. G. [1 ,3 ,4 ]
Leufkens, H. G. M. [4 ]
机构：
[1] Univ Med Ctr Utrecht, EPHOR, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Geriatr, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands
[4] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [21] Availability of information on geriatric dosing for potentially inappropriate medications in summary product characteristics
    Kolenikova, J.
    Kostriba, J.
    Lukacisinova, A.
    Fialova, D.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1540 - 1540
  • [22] What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics
    Albassam, Abdullah
    Hughes, Dyfrig A.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (02) : 251 - 260
  • [23] What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics
    Abdullah Albassam
    Dyfrig A. Hughes
    [J]. European Journal of Clinical Pharmacology, 2021, 77 : 251 - 260
  • [24] Availability of information about old people in SmPCs and EPARs: an evaluation of thirty recently approved drugs
    Beers, E.
    Jansen, P. A.
    Egberts, A. C.
    Leufkens, H. G.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (04) : 706 - 706
  • [25] The evidence base for psychotropic drugs approved by the European Medicines Agency: a meta-assessment of all European Public Assessment Reports
    Erhel, Florian
    Scanff, Alexandre
    Naudet, Florian
    [J]. EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2020, 29
  • [26] The evidence base for psychotropic drugs approved by the European Medicines Agency: a meta-assessment of all European Public Assessment Reports
    Erhel, F.
    Scanff, A.
    Naudet, F.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 52 - 53
  • [27] Arterial Hyper- and Hypotension associated with psychiatric medications: a risk assessment based on the summaries of product characteristics (SmPCs)
    Freudenmann, Roland W.
    Freudenmann, Ninja
    Zurowski, Bartosz
    Schoenfeldt-Lecuona, Carlos
    Maier, Ludwig
    Schmieder, Roland E.
    Lange-Asschenfeldt, Christian
    Gahr, Maximilian
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (16) : E100 - E107
  • [28] The medium is not the message: A content analysis of public information about vaping product regulations in Australia
    Saw, Kyle Eu Soon
    Morphett, Kylie
    Puljevic, Cheneal
    Bromberg, Marilyn
    Gartner, Coral
    [J]. DRUG AND ALCOHOL REVIEW, 2019, 38 (05) : 569 - 578
  • [29] Is information for dose adjustment in renal impairment contained in Summaries of Product Characteristics suitable for integration in clinical decision support systems?
    Salgado, T. M.
    Arguello, B.
    Martinez-Martinez, F.
    Benrimoj, S. I.
    Fernandez-Llimos, F.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1271 - 1271
  • [30] Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative Analysis
    Then, Melanie, I
    Andrikyan, Wahram
    Fromm, Martin F.
    Maas, Renke
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
12345